Credit Suisse’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
$3.7M Buy
134,497
+317
+0.2% +$8.72K ﹤0.01% 1463
2023
Q4
$4.09M Buy
134,180
+12,493
+10% +$381K ﹤0.01% 1449
2023
Q3
$3.85M Sell
121,687
-3,221
-3% -$102K ﹤0.01% 1413
2023
Q2
$5.09M Buy
124,908
+22,188
+22% +$905K 0.01% 1311
2023
Q1
$3.83M Buy
102,720
+10,163
+11% +$379K ﹤0.01% 1476
2022
Q4
$3.23M Buy
92,557
+9,549
+12% +$333K ﹤0.01% 1586
2022
Q3
$4.64M Sell
83,008
-888
-1% -$49.7K 0.01% 1284
2022
Q2
$4.34M Sell
83,896
-15,883
-16% -$822K ﹤0.01% 1366
2022
Q1
$7.25M Buy
99,779
+28,702
+40% +$2.09M 0.01% 1197
2021
Q4
$8.41M Sell
71,077
-8,619
-11% -$1.02M ﹤0.01% 1206
2021
Q3
$10.7M Sell
79,696
-18,581
-19% -$2.49M 0.01% 1103
2021
Q2
$15.9M Buy
98,277
+17,640
+22% +$2.86M 0.01% 934
2021
Q1
$6.47M Sell
80,637
-21,649
-21% -$1.74M ﹤0.01% 1381
2020
Q4
$5.56M Sell
102,286
-26,087
-20% -$1.42M ﹤0.01% 1454
2020
Q3
$2.55M Buy
128,373
+20,737
+19% +$412K ﹤0.01% 1663
2020
Q2
$2.26M Buy
107,636
+47,181
+78% +$992K ﹤0.01% 1777
2020
Q1
$739K Buy
60,455
+19,825
+49% +$242K ﹤0.01% 2318
2019
Q4
$595K Buy
40,630
+15,479
+62% +$227K ﹤0.01% 2814
2019
Q3
$335K Sell
25,151
-1,063
-4% -$14.2K ﹤0.01% 2993
2019
Q2
$428K Buy
26,214
+6,215
+31% +$101K ﹤0.01% 2866
2019
Q1
$341K Sell
19,999
-6,639
-25% -$113K ﹤0.01% 2969
2018
Q4
$363K Buy
26,638
+1,472
+6% +$20.1K ﹤0.01% 2899
2018
Q3
$721K Sell
25,166
-10,165
-29% -$291K ﹤0.01% 2628
2018
Q2
$967K Buy
35,331
+5,065
+17% +$139K ﹤0.01% 2595
2018
Q1
$638K Buy
30,266
+4,390
+17% +$92.5K ﹤0.01% 2827
2017
Q4
$498K Buy
25,876
+2,338
+10% +$45K ﹤0.01% 2953
2017
Q3
$585K Buy
+23,538
New +$585K ﹤0.01% 2986
2017
Q1
Sell
-12,379
Closed -$162K 3540
2016
Q4
$162K Sell
12,379
-2,061
-14% -$27K ﹤0.01% 3508
2016
Q3
$245K Buy
+14,440
New +$245K ﹤0.01% 3399